ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1642

Automated Nailfold Capillary Counting System (AUTOCAPI) in Systemic Sclerosis Patients with Different Capillaroscopic Patterns

Alberto Sulli1, Amber Vanhaecke 2, Carmen Pizzorni 3, Giorgia Ferrari 4, Veronica Tomatis 5, Monica Pendolino 4, Vanessa Smith 6 and Maurizio Cutolo 4, 1Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Genoa, Italy, 2Dept. of Rheumatology, Ghent University Hospital, Ghent, Belgium; Dept. of Internal Medicine, Ghent University, Ghent, Belgium, Ghent, Belgium, 3Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino Polyclinic Hospital, Genoa, Italy, Genoa, Italy, 4Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Genoa, Italy, 5Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Ospedale Policlinico San Martino, Genova, Italy, Genoa, Italy, 6Dept. of Rheumatology, Ghent University Hospital, Ghent, Belgium; Dept. of Internal Medicine, Ghent University, Ghent, Belgium; Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Center (IRC), Ghent, Belgium, Gent, Belgium

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: scleroderma and nailfold capillaroscopy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Systemic Sclerosis & Related Disorders – Clinical Poster II

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Nailfold videocapillaroscopy (NVC) allows assessment of possible microvascular markers of severity and progression in systemic sclerosis (SSc), such as reduced capillary number, which has been associated with a high risk of developing disease complications (1-2). An automated capillary counting system (AUTOCAPI) has recently been validated in SSc patients (3). The aim of this study was to evaluate the performance of this automated software for absolute nailfold capillary number counting, in SSc patients with different NVC patterns of microangiopathy (Early, Active, and Late).

Methods: 183 SSc patients were random collected and enrolled at both Genova and Ghent Divisions of Rheumatology (LeRoy 2001 or ACR 2013 criteria, mean age 55±13 year, mean disease duration 5.5±6.8 years) and classified by NVC in one the following patterns: 28 “not specific”, 37 “Early”, 89 “Active”, 29 “Late”) (4). Eight fingers for each patient were analysed, counting the number of nailfold capillaries manually and by the AUTOCAPI software (DS Medica, Italy) along a millimetre in each finger image (3). The mean capillary number value from the eight finger images was calculated. The software reliability was assessed through calculation of the intraclass correlation coefficient (ICC) between automatic and manual counting.

Results: The mean number of capillaries assessed by manual vs automatic counting was as follows: 5.23±1.7 vs 5.47±1.3 in the total group of SSc patients, 5.91±1.2 vs 6.87±1.2 in the “not specific”, 7.23±1.4 vs 5.67±1.1 in the “early”, 4.67±1.1 vs 5.16±1.2 in the “active” and 3.72±1.5 vs 4.85±1.1 in the “Late” pattern of microangiopathy.The higher standard deviation observed for automatic counting was 1.23 in the “not specific” group. The following ICC’s were obtained respectively for total patients, “not specific”, “Early”, “Active”, and “Late” NVC patterns: 0.53, 0.51, 0.48, 0.50 and 0.66. The mean values for the manual versus automatic capillary counting assessed by the two centres in all SSc patients were respectively: 5.92±1.8 and 5.02±1.1 for Genova centre, and 4.71±1.5 and 5.83±1.4 for Ghent centre. The automatic counting confirmed that capillary number progressively reduces from “Early” to “Active” to “Late” NVC pattern of microangiopathy in SSc.

Conclusion: This study demonstrates the good reliability of AUTOCAPI software in nailfold capillary number counting in SSc patients with different patterns of microangiopathy. The use of automated counting software allows to standardize nailfold capillary assessment among different Rheumatologic centres. 

References. 1. Cutolo M, et al. Arthritis Rheumatol. 2016;68:2527-39.  2. Smith V, et al. J Rheumatol. 2013;40:2023-8.  3. Cutolo M, et al. Microcirculation. 2018;25:e12447.  4. Sulli A, et al, Arthritis Rheum 2012;64:821-5.


Disclosure: A. Sulli, None; A. Vanhaecke, None; C. Pizzorni, None; G. Ferrari, None; V. Tomatis, None; M. Pendolino, None; V. Smith, None; M. Cutolo, Boehringer, Actelion, Celgene, Bristol-Mayer Squibb, 2.

To cite this abstract in AMA style:

Sulli A, Vanhaecke A, Pizzorni C, Ferrari G, Tomatis V, Pendolino M, Smith V, Cutolo M. Automated Nailfold Capillary Counting System (AUTOCAPI) in Systemic Sclerosis Patients with Different Capillaroscopic Patterns [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/automated-nailfold-capillary-counting-system-autocapi-in-systemic-sclerosis-patients-with-different-capillaroscopic-patterns/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/automated-nailfold-capillary-counting-system-autocapi-in-systemic-sclerosis-patients-with-different-capillaroscopic-patterns/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology